๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-04

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy (NCT06979362)

Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

๐ŸŸข Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Novo Nordisk A/S

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (a medicine which has no effect on the body), which treatment the participants get is decided by chance. The study will last for about 60 weeks.

Who can join: Review the eligibility criteria below.

Location: Univ of Alabama Birmingham โ€” Birmingham, Alabama

Age range: 40 Years to 84 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (117 Sites)

Showing the first 25 of 117 sites.

  • Univ of Alabama Birmingham โ€” Birmingham, Alabama
  • TMC Hlthcr Clin Res Office โ€” Tucson, Arizona
  • Pima Heart and Vascular โ€” Tucson, Arizona
  • Valley Clinical Trials โ€” Covina, California
  • UCSD NAFLD Research Center โ€” La Jolla, California
  • Valley Clinical Trials โ€” Northridge, California
  • University of California, San Francisco โ€” San Francisco, California
  • University of California San Francisco UCSF โ€” San Francisco, California
  • Harbor-UCLA Medical Center โ€” Torrance, California
  • Univ of Colorado at Denver โ€” Aurora, Colorado
  • Inpatient Research Clinic LLC โ€” Miami Lakes, Florida
  • AdventHealth Orlando โ€” Orlando, Florida
  • Guardian Research Org LLC โ€” Winter Park, Florida
  • UofL Health Care Outpatient โ€” Louisville, Kentucky
  • Henry Ford Hospital_Detroit โ€” Detroit, Michigan
  • University of Minnesota_Minneapolis_1 โ€” Minneapolis, Minnesota
  • Washington University School of Medicine โ€” St Louis, Missouri
  • Icahn Sch of Med-Mt Sinai Hosp โ€” New York, New York
  • Duke University โ€” Durham, North Carolina
  • Providence St. Vincent Heart โ€” Portland, Oregon
  • Abington Memorial Hospital โ€” Abington, Pennsylvania
  • Capital Area Research LLC โ€” Camp Hill, Pennsylvania
  • Vanderbilt University Medical Center โ€” Nashville, Tennessee
  • Amarillo Medical Specialists โ€” Amarillo, Texas
  • University of Texas Southwestern Medical Center โ€” Dallas, Texas

๐Ÿ“ž Contact the Study Coordinator

Phone: (866) 867-7178

Email: clinicaltrials@novonordisk.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Heart Failure clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—